Free Trial

Co-Diagnostics Q2 2024 Earnings Report

Co-Diagnostics logo
$0.31 -0.01 (-3.84%)
As of 03:59 PM Eastern

Co-Diagnostics EPS Results

Actual EPS
-$0.25
Consensus EPS
-$0.34
Beat/Miss
Beat by +$0.09
One Year Ago EPS
N/A

Co-Diagnostics Revenue Results

Actual Revenue
$2.66 million
Expected Revenue
$0.40 million
Beat/Miss
Beat by +$2.26 million
YoY Revenue Growth
N/A

Co-Diagnostics Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

Co-Diagnostics Earnings Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More Co-Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Co-Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Co-Diagnostics and other key companies, straight to your email.

About Co-Diagnostics

Co-Diagnostics (NASDAQ:CODX), a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

View Co-Diagnostics Profile

More Earnings Resources from MarketBeat